We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current NEXI market cap is 3.4M. The company's latest EPS is USD -30.5673 and P/E is -0.11.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -17.25M | -9.83M | -7.79M | -10M | -5.37M |
| Net Income | -16.89M | -9.57M | -7.57M | -9.85M | -5.36M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -20.89M | -27.85M | -53.26M | -63.08M | -32.97M |
| Net Income | -23.21M | -33.15M | -51.28M | -62.51M | -32.34M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 43.06M | 30.66M | 23.47M | 14.56M | 8.59M |
| Total Liabilities | 10.76M | 7.09M | 6.47M | 6.31M | 5.08M |
| Total Equity | 32.3M | 23.58M | 17M | 8.25M | 3.51M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 13.72M | 11.3M | 91.03M | 43.06M | 8.59M |
| Total Liabilities | 3.11M | 27.06M | 7.27M | 10.76M | 5.08M |
| Total Equity | -43.01M | -69.38M | 83.76M | 32.3M | 3.51M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -51.19M | -12.28M | -18.31M | -25.6M | -31.43M |
| Investing | 50.32M | -43k | -48k | -45k | -45k |
| Financing | 5.18M | N/A | N/A | N/A | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.42M | -26.4M | -45.79M | -51.19M | -31.43M |
| Investing | 9.42M | 222k | -53.81M | 50.32M | -45k |
| Financing | 18.77M | 22.09M | 124.89M | 5.18M | N/A |
| Market Cap | 3.4M |
| Price to Earnings Ratio | -0.11 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.06 |
| Price to Book Ratio | 0.97 |
| Dividend Yield | - |
| Shares Outstanding | 1.06M |
| Average Volume (1 week) | 9.61k |
| Average Volume (1 Month) | 16k |
| 52 Week Change | -68.16% |
| 52 Week High | 28.405 |
| 52 Week Low | 1.2501 |
| Spread (Intraday) | 1.34 (38.07%) |
| Company Name | NexImmune Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.neximmune.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
